245PD - Duration of response and tumor shrinkage with first-line ribociclib + letrozole in postmenopausal women with HR+, HER2– ABC
| Autor: | Janni, W., Alba Conejo, E., Bachelot, T., Diab, S., Gil-Gil, M., Beck, T.J., Ryvo, L., López, R., Tsai, M., Esteva, F.J., Zamora Aunon, M.P., Kral, Z., Ward, P., Richards, P., Pluard, T.J., Sutradhar, S., Miller, M., Campone, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v78-v78 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|